News Archive

Using the power of bioinformatics, GI scientists turned cancer researchers find that elevated levels of molecular motor Myo5b are implicated in uterine cancer.

An MUSC Hollings Cancer Center team has created what members believe to be among the first small molecules designed to stimulate immune cells to fight cancer.

An MUSC Hollings Cancer Center doctor is one of only 12 chosen to participate in the National Cancer Institute’s Early-stage Surgeon Scientist Program.

891 riders and 105 teams raised more than $427,000 to make LOWVELO22 the biggest yet.

MUSC Hollings Cancer Center is investing in its scientists' research, providing pilot grants to help projects to get started.

A type of cell that plays a key role in pancreatic cancer can trace its origin back to a structure that forms during embryonic development.

MUSC Hollings Cancer Center’s Benjamin Toll, Ph.D., is thrilled to be elected to help lead the Society for Research on Nicotine & Tobacco.

Hollings Cancer Center director Raymond N. DuBois, M.D., Ph.D., honored two of the center’s up-and-coming researchers with the High Impact Publications Award.

A casual brainstorming session led Hollings researchers to consider how two systems within the body might be "talking" - and enabling cancers to grow.

Playing “serious” games can be an effective and engaging way to teach teamwork and other skills to robotic surgery teams.